pGenHT 1.0-DGV vector plasmid悬浮细胞高效工业级表达载体质粒 BioVector NTCC质粒载体菌种细胞基因保藏中心

After serum-free suspension adaption and characterization, BioVector acquires the host cell for CHOK1-GenS cell line development system without chemical modification. In together with the high-expression proprietary pGenHT 1.0-DGV vector, the yield titer can reach an average of 4.35g/L , up to 8.70g/L.

The CHOK1-GenS system has been used in 40+ CMC&CMO projects in which 11 has got IND approvals.

细胞系开发是生物药研发重要一环，链接了药物发现与临床前开发，是临床前 CMC 开发的限速步骤。BioVector细胞系开发使用自主宿主细胞、表达载体，开发周期短，具有优质的交付记录和项目开发经验。

而BioVector保藏中心的 BioVector CHOK1-GenS 细胞系表达系统经过无血清悬浮驯化和检定后得到，未

经过基因改造，可以对外商业化授权，搭配自主开发的 pGenHT 1.0-DGV BioVector载体，能够保证出色的抗体量表达（平均 4.35g/L，最高 8.7g/L）。

Supplier来源:BioVector NTCC Inc.
TEL电话:+86-010-53513060
Website网址: http://www.biovector.net